CXCL13促进由循环RNA疫苗诱导的广泛免疫反应
Jiawu Wan1,2,3,4, Caiqian Wang1,2,3,4, Zongmei Wang1,2,3,4
1National Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan 430070, China.
概括
这项研究开发了一种新的循环RNA (circRNA) 疫苗平台,使用脂质纳米粒子 (LNP) 增强免疫反应. 该平台增强了对流感和SARS-CoV-2的交叉反应性抗体,提供了更广泛的保护.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 分子生物学分子生物学
背景情况:
- 目前的流感和SARS-CoV-2疫苗的交叉反应性有限.
- 淋巴结 (LNs) 是影响疫苗疗效的关键免疫微环境.
- 开发具有针对多种病毒病原体的广泛保护的疫苗是一个重大挑战.
研究的目的:
- 设计一种基于脂质纳米粒子 (LNP) 的循环RNA (circRNA) 疫苗平台,用于增强和交叉反应性抗体反应.
- 研究CXCL13在调节淋巴结免疫微环境中的作用,以提高疫苗的疗效.
- 评估开发的疫苗平台对同源和异源流感病毒挑战的保护潜力.
主要方法:
- 配送抗原编码circRNA和CXCL13的LNP的设计,向淋巴结.
- 在接种疫苗后对LNs的转录基因变化的分析.
- 在小鼠模型中评估生殖中心形成,T细胞反应和抗体交叉反应.
- 使用针对抗体的LNP表面修饰评估疫苗的稳定性和储存.
主要成果:
- 整合到circRNA中的CXCL13显著改变了LN转录组概况,上调了IL-21和IL-4.
- circRNA-CXCL13系统促进了生殖中心的形成和强大的抗原特异性T细胞反应.
- 与抗原增强交叉反应性抗体对抗流感和SARS-CoV-2同时提供CXCL13.
- 该疫苗在小鼠中提供了对同源和异源流感病毒挑战的保护.
- 有针对性的LNP修改改善了冷化circRNA疫苗的稳定性.
结论:
- 基于circRNA的抗原-CXCL13联合表达系统为增强抗体反应的大小和广度提供了一个强大的平台.
- CXCL13在调节淋巴结微环境中起着关键作用,以诱导广泛的免疫反应.
- 该平台有可能开发下一代针对多种病毒葡萄糖蛋白的疫苗,包括流感和SARS-CoV-2.
- 针对性的LNP修改对于实际应用和长期储存circRNA疫苗至关重要.
相关概念视频
02:15Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
01:23RNA Interference
25.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.9K
01:22T Cell Activation and Clonal Selection
674
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
674